(Q69660212)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3779716%20AND%20SRC:MED&resulttype=core&format=json

4 October 2019

title

BCG immunotherapy in stage I melanoma patients. Does it influence prognosis determined by HLA-DR expression in high-risk primary tumors? (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3779716%20AND%20SRC:MED&resulttype=core&format=json

4 October 2019

1 reference

E B Bröcker

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3779716%20AND%20SRC:MED&resulttype=core&format=json

4 October 2019

L Suter

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3779716%20AND%20SRC:MED&resulttype=core&format=json

4 October 2019

B M Czarnetzki

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3779716%20AND%20SRC:MED&resulttype=core&format=json

4 October 2019

E Macher

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3779716%20AND%20SRC:MED&resulttype=core&format=json

4 October 2019

publication date

1 January 1986

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3779716%20AND%20SRC:MED&resulttype=core&format=json

Cancer Immunology, Immunotherapy

4 October 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3779716%20AND%20SRC:MED&resulttype=core&format=json

4 October 2019

volume

23

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3779716%20AND%20SRC:MED&resulttype=core&format=json

4 October 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3779716%20AND%20SRC:MED&resulttype=core&format=json

4 October 2019

page(s)

155-157

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3779716%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/bf00199823

4 October 2019

exact match

0 references

cites work

Phenotypic dynamics of tumor progression in human malignant melanoma

1 reference

12 December 2020

The natural history of resectable metastatic melanoma (Stage IVA melanoma).

1 reference

12 December 2020

Strain variation in interferon gamma production of BCG-sensitized mice challenged with PPD II. Importance of one major autosomal locus and additional sexual influences

1 reference

12 December 2020

Recombinant interferon-gamma can induce the expression of HLA-DR and -DC on DR-negative melanoma cells and enhance the expression of HLA-ABC and tumor-associated antigens.

1 reference

12 December 2020

Suppression of BCG cell wall-induced delayed-type hypersensitivity by pretreatment with killed BCG: induction of nonspecific suppressor T cells by the adjuvant portion (MDP) and of specific suppressor T cells by the antigen portion (TAP)

1 reference

12 December 2020

The inhibition of lymphocyte stimulation by autologous human metastatic melanoma cells correlates with the expression of HLA-DR antigens on the tumor cells

1 reference

12 December 2020

Suppressor cells induced by BCG release non-specific factors in vitro which inhibit DNA synthesis and interleukin-2 production

1 reference

12 December 2020

Negative and positive immunobiological responses in mice pretreated with Bacillus Calmette-Guérin cell wall

1 reference

12 December 2020

Adjuvant BCG immunotherapy for malignant melanoma

1 reference

12 December 2020

A monoclonal antibody to a formaldehyde-resistant epitope on the nonpolymorphic constant part of the HLA-DR antigens.

1 reference

12 December 2020

Migration inhibitory factor and type II interferon in the circulation of mice sensitized with mycobacterial components

1 reference

12 December 2020

HLA-DR Antigen Expression in Primary Melanomas of the Skin

1 reference

12 December 2020

Value of adjuvant therapy with bacille Calmette Guerin (BCG) or dimethl triazeno imidazole carboximide (DTIC) in the control of minimal residual disease in stage II melanoma

1 reference

12 December 2020

Mode of immunopotentiating action of BCG: macrophage activation produced by BCG-infection

1 reference

12 December 2020

Effect of Bacillus Calmette-Guérin Infection on Transplanted Tumours in the Mouse

1 reference

12 December 2020

Surface antigens of melanoma and melanocytes. Specificity of induction of Ia antigens by human gamma-interferon

1 reference

12 December 2020

A randomized trial of adjuvant chemotherapy and immunotherapy in cutaneous melanoma

1 reference

12 December 2020

Facilitation and inhibition of b16 melanoma by BCG in vivo and by lymphoid cells from bcg-treated mice in vitro

1 reference

12 December 2020

A randomized trial of adjuvant chemotherapy and immunotherapy in Stage I and Stage II cutaneous melanoma. An interim report

1 reference

12 December 2020

Inhibition of in vitro cytotoxic responses by BCG-induced macrophage-like suppressor cells. II. Suppression occurs at the level of a "helper" T cell

1 reference

12 December 2020

BCG-induced suppressor cells. I. Demonstration of a macrophage-like suppressor cell that inhibits cytotoxic T cell generation in vitro

1 reference

12 December 2020

Reduction of bladder tumor growth in mice treated with intravesical Bacillus Calmette-Guérin and its correlation with Bacillus Calmette-Guérin viability and natural killer cell activity

1 reference

12 December 2020

Effectiveness of systemic BCG therapy in advanced melanoma

1 reference

12 December 2020

Interferon Production by Corynebacterium Parvum and BCG-Activated Murine Spleen Macrophages

1 reference

12 December 2020

Systemic bacillus Calmette-Guérin (BCG) activates natural suppressor cells

1 reference

12 December 2020

Cytokinetics of macrophage-mediated cytotoxicity.

1 reference

12 December 2020

The effect of BCG on B16 mouse melanoma: a comparison of routes of administration on tumour growth at different anatomical sites

1 reference

12 December 2020